4-甲基伞形酮抑制眼眶成纤维细胞透明质酸合成的特征
本研究在体外观察4-甲基伞形酮(4-MU)对Graves眼眶病(GO)眼眶成纤维细胞透明质酸(HA)合成的影响。结果发现4-MU(1 mM,24小时)平均减少87%的HA合成、降低HAS2表达80%、增加HYAL2表达2.5倍,并将细胞增殖率平均降至16%,且不影响细胞活力。
要点
- 4-MU(1 mM,24小时)平均减少87%的HA合成(P < 0.001)。
- 4-MU降低HAS2表达80%、增加HYAL2表达2.5倍,并将增殖率降至平均16%。
- 4-MU抑制TGF-β刺激的HA产生,机制涉及抑制刺激后的HAS1表达。
核心结论
- 4-MU在体外抑制眼眶成纤维细胞的HA合成和增殖率,且不影响细胞活力。
- 4-MU对HA合成的抑制特征在眼眶成纤维细胞与真皮成纤维细胞间无差异。
研究设计与样本
- 体外细胞实验,比较GO眼眶(n = 4)、非GO眼眶(n = 4)和真皮来源(n = 4)成纤维细胞在有无4-MU及有无TGF-β刺激下的反应。
主要发现
- 4-MU(1 mM)处理24小时使HA合成平均减少87%(P < 0.001)。
- 4-MU使主要HAS亚型HAS2表达降低80%(P < 0.0001),并使HYAL2表达增加2.5倍(P < 0.001)。
- 4-MU使所有研究细胞系的增殖率平均降至16%(P < 0.0001),且不影响细胞活力。
- 4-MU降低TGF-β刺激的HA产生,机制包括抑制刺激后的HAS1表达。
临床怎么用
- 4-MU可作为GO的候选治疗药物,但当前证据仅限于体外细胞实验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hyaluronan (HA) overproduction by orbital fibroblasts (OFs) is a major factor in the pathogenesis of Graves' orbitopathy (GO). 4-methylumbelliferone (4-MU) is an inhibitor of HA synthesis in different cell types in vitro and has beneficial effects in animal models of autoimmune diseases. METHODS: HA production and mRNA expression of HA synthases (HAS1, HAS2, and HAS3) and hyaluronidases (HYAL1 and HYAL2) were measured in the presence and absence of 4-MU in unstimulated and transforming growth factor-β-stimulated fibroblasts from GO orbital (n = 4), non-GO orbital (n = 4), and dermal origin (n = 4). RESULTS: The 4-MU treatment (1 mM) for 24 hours resulted in an average 87% reduction (P < 0.001) of HA synthesis, decreased the expression of the dominant HAS isoform (HAS2) by 80% (P < 0.0001), and increased the HYAL2 expression by 2.5-fold (P < 0.001) in control OFs, GO OFs, and dermal fibroblasts (DFs) regardless of the origin of the cells. The proliferation rate of all studied cell lines was reduced to an average 16% by 4-MU (P < 0.0001) without any effects on cell viability. HA production stimulated by transforming growth factor-β was decreased by 4-MU via inhibition of stimulated HAS1 expression in addition to the observed effects of 4-MU in unstimulated cases. Characteristics of HA synthesis inhibition by 4-MU did not differ in OFs compared with DFs. CONCLUSIONS: 4-MU has been found to inhibit the HA synthesis and the proliferation rate in OFs in vitro, adding it to the list of putative therapeutic agents in a disease the cure of which is largely unresolved.
引用
- Galgoczi E, Jeney F, Katko M, et al. Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2020. PMID: 32084270. doi:10.1167/iovs.61.2.27
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。